rogocekib   Click here for help

GtoPdb Ligand ID: 13217

Synonyms: CTX-712 | CTX712
Compound class: Synthetic organic
Comment: The chemical structure for rogocekib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a dual specificity protein kinase CLK (CDC2-like kinase) inhibitor with proposed antineoplastic action. A structure match via PubChem identified the clinical research code CTX-712 (Chordia Therapeutics). CTX-712 is an orally available, potent CLK inhibitor.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 0
Rotatable bonds 5
Topological polar surface area 99.1
Molecular weight 408.39
XLogP 2.02
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@H](C1=NN=C(CN2C(=NC3=NC=C(C=C32)C4=C5C(=NC=NN5C=C4)OC)C)O1)F
Isomeric SMILES CC1=NC2=C(N1CC3=NN=C(O3)[C@@H](C)F)C=C(C=N2)C4=C5C(=NC=NN5C=C4)OC
InChI InChI=1S/C19H17FN8O2/c1-10(20)18-26-25-15(30-18)8-27-11(2)24-17-14(27)6-12(7-21-17)13-4-5-28-16(13)19(29-3)22-9-23-28/h4-7,9-10H,8H2,1-3H3/t10-/m1/s1
InChI Key OENNTZBJPRRGFL-SNVBAGLBSA-N
References
1. Tang J, Xie Y, Huang J, Zhang L, Jiang W, Li Z, Bian J. (2022)
A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing.
Bioorg Med Chem, 70: 116921. [PMID:35863237]